Guilherme Sant'Anna

Dr. Guilherme Sant'Anna

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JYJae-Young Yoo
Jae-Young Yoo
SOSeyong Oh
Seyong Oh
WSWissam Shalish
Wissam Shalish
WMWoo-Youl Maeng
Woo-Youl Maeng
ECEmily Cerier
Emily Cerier
John A. RogersJohn A. Rogers
John A. Rogers

2 November 2017 in Journal of Perinatology
Verified
Journal Article
Open access
PDF file
CPC Prempunpong
C Prempunpong
LCL F Chalak
L F Chalak
JGJ Garfinkle
J Garfinkle
Birju A. ShahBirju A. Shah
Birju A. Shah
VKV Kalra
V Kalra
GSGuilherme Sant'Anna
Guilherme Sant'Anna
Objective: To determine short-term outcomes of infants with evidence of hypoxia–ischemia at birth and classified as mild neonatal encephalopathy (NE) at <6 h of age. Study Design: Prospective multicenter study. Mild NE was defined as ⩾1 abnormal category in modified Sarnat score. Primary outcome was any abnormality on early amplitude integrated electroencephalogram (aEEG) or seizures, abnormal brain magnetic resonance imaging (MRI) or neurological exam at discharge. Results: A total of 54/63 (86%) of enrolled infants had data on components of the primary outcome, which was abnormal in 28/54 (52%): discontinuous aEEG (n=4), MRI (n=9) and discharge exam (n=22). Abnormal tone and/or incomplete Moro were the most common findings. MRI abnormalities were confined to cerebral cortex but two infants had basal ganglia and/or thalamus involvement. The 18 to 24 months follow-up is ongoing. Conclusions: A larger than expected proportion of mild NE infants with abnormal outcomes was observed. Future research should evaluate safety and efficacy of neuroprotection for mild NE.

1 February 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
WSWissam Shalish
Wissam Shalish
LKLara Kanbar
Lara Kanbar
LKLajos Kovacs
Lajos Kovacs
SCSanjay Chawla
Sanjay Chawla
MKMartin Keszler
Martin Keszler
GSGuilherme Sant'Anna
Guilherme Sant'Anna

2 May 2020 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
WSWissam Shalish
Wissam Shalish
SLSatyan Lakshminrusimha
Satyan Lakshminrusimha
PMPaolo Manzoni
Paolo Manzoni
MKMartin Keszler
Martin Keszler
GSGuilherme Sant'Anna
Guilherme Sant'Anna
The novel coronavirus disease 2019 (COVID-19) pandemic has urged the development and implementation of guidelines and protocols on diagnosis, management, infection control strategies, and discharge planning. However, very little is currently known about neonatal COVID-19 and severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) infections. Thus, many questions arise with regard to respiratory care after birth, necessary protection to health care workers (HCW) in the delivery room and neonatal intensive care unit (NICU), and safety of bag and mask ventilation, noninvasive respiratory support, deep suctioning, endotracheal intubation, and mechanical ventilation. Indeed, these questions have created tremendous confusion amongst neonatal HCW. In this manuscript, we comprehensively reviewed the current evidence regarding COVID-19 perinatal transmission, respiratory outcomes of neonates born to mothers with COVID-19 and infants with documented SARS-CoV-2 infection, and the evidence for using different respiratory support modalities and aerosol-generating procedures in this specific population. The results demonstrated that to date, neonatal COVID-19 infection is uncommon, generally acquired postnatally, and associated with favorable respiratory outcomes. The reason why infants display a milder spectrum of disease remains unclear. Nonetheless, the risk of severe or critical illness in young patients exists. Currently, the recommended respiratory approach for infants with suspected or confirmed infection is not evidence based but should include all routinely used types of support, with the addition of viral filters, proper personal protective equipment, and placement of infants in isolation rooms, ideally with negative pressure. As information is changing rapidly, clinicians should frequently watch out for updates on the subject. Key Points W.S. and G.M.S. conceptualized and designed the review, drafted the initial manuscript, and reviewed and revised the manuscript. P.M. and M.K. reviewed the extracted data and analyses of the cases and reviewed and revised the final manuscript including all tables and figures. S.L. conceptualized and designed all figures, participated on several drafts of the manuscript, and reviewed and revised the final manuscript, including all tables. All authors critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

1 February 2020 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
WSWissam Shalish
Wissam Shalish
LKLara Kanbar
Lara Kanbar
LKLajos Kovacs
Lajos Kovacs
SCSanjay Chawla
Sanjay Chawla
MKMartin Keszler
Martin Keszler
GSGuilherme Sant'Anna
Guilherme Sant'Anna
Extremely preterm neonates (gestational age ≤28 weeks) commonly require mechanical ventilation after birth.1 Given the known harms associated with prolonged mechanical ventilation, clinicians strive to limit mechanical ventilation exposure by routinely assessing neonates’ readiness for extubation.2 Currently, the decision to extubate relies on clinical judgment through interpretation of ventilatory support, blood gas values, and overall clinical stability of the neonate.3,4 However, clinical judgment is subjective, leads to variable practices, and is often associated with inaccurate decisions.3 In fact, nearly one-third of neonates require reintubation within 7 days after the first extubation attempt.5

17 July 2017 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
WSWissam Shalish
Wissam Shalish
LKLara J. Kanbar
Lara J. Kanbar
SRSmita Rao
Smita Rao
CRCarlos A. Robles-Rubio
Carlos A. Robles-Rubio
LKLajos Kovacs
Lajos Kovacs
GSGuilherme Sant'Anna
Guilherme Sant'Anna
Extremely preterm infants (≤ 28 weeks gestation) commonly require endotracheal intubation and mechanical ventilation (MV) to maintain adequate oxygenation and gas exchange. Given that MV is independently associated with important adverse outcomes, efforts should be made to limit its duration. However, current methods for determining extubation readiness are inaccurate and a significant number of infants fail extubation and require reintubation, an intervention that may be associated with increased morbidities. A variety of objective measures have been proposed to better define the optimal time for extubation, but none have proven clinically useful. In a pilot study, investigators from this group have shown promising results from sophisticated, automated analyses of cardiorespiratory signals as a predictor of extubation readiness. The aim of this study is to develop an automated predictor of extubation readiness using a combination of clinical tools along with novel and automated measures of cardiorespiratory behavior, to assist clinicians in determining when extremely preterm infants are ready for extubation. In this prospective, multicenter observational study, cardiorespiratory signals will be recorded from 250 eligible extremely preterm infants with birth weights ≤1250 g immediately prior to their first planned extubation. Automated signal analysis algorithms will compute a variety of metrics for each infant, and machine learning methods will then be used to find the optimal combination of these metrics together with clinical variables that provide the best overall prediction of extubation readiness. Using these results, investigators will develop an Automated system for Prediction of EXtubation (APEX) readiness that will integrate the software for data acquisition, signal analysis, and outcome prediction into a single application suitable for use by medical personnel in the neonatal intensive care unit. The performance of APEX will later be prospectively validated in 50 additional infants. The results of this research will provide the quantitative evidence needed to assist clinicians in determining when to extubate a preterm infant with the highest probability of success, and could produce significant improvements in extubation outcomes in this population. Clinicaltrials.gov identifier: NCT01909947 . Registered on July 17 2013. Trial sponsor: Canadian Institutes of Health Research (CIHR).